← All indications
Uterine Cervical Dysplasia
Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE.
Subtype terms (2)
More specific conditions that are subtypes of Uterine Cervical Dysplasia in the MeSH hierarchy.
- Atypical Squamous Cells of the Cervix
8 drugs (1 approved, 7 experimental)
- Squamous Intraepithelial Lesions of the Cervix
2 drugs experimental
Drugs by status
Phase 4 trials (1)
Phase 3 trials (10)
Phase 2 trials (7)
Phase 1 trials (4)
Other trials (5)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (9)
Organization Involved with Phase 2 Indications (37)
- Photocure
- Kirax
- Planned Parenthood
- The University of Texas Health Science Center, Houston
- University of Pittsburgh
- Augusta University
- Georgetown University
- Gottfried Wilhelm Leibniz Universität Hannover
- Jersey Shore University Medical Center
- Johns Hopkins University
- University of Oklahoma
- University of South Florida
- Yale University
- University of California, Irvine
- University of Vienna
- University of the Witwatersrand
- Visions Clinical Research
- Physician Care Clinical Research LLC
- University of Texas at Houston
- Robin Black OGNP, Costa Mesa California
- University of Alabama
- OB/GYN Specialists of the Palm Beaches
- Mount Vernon Clinical Research, LLC
- Northern California Research Corp
- Hope Research Institute, LLC
- Coastal Connecticut Research, LLC
- Greater Cincinnati OB/GYN, Inc.
- IGO Medical Group of San Diego
- Hill Country OB/GYN
- South Carolina Oncology Associates
- +7 more
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (2)